http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020275931-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6c964a2b90f5ccb0169ecc2c70287d1
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00889
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00893
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-00063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-085
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-00
filingDate 2018-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29d39a906dfa429e723ee8bbc298b44a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb79e0665a06fac1250dff7d6baf5d04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1376c142d95de7d0a9a6bdd44a94983
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c2ddc726bd3cdd18c7ea7d3314ad4af
publicationDate 2020-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2020275931-A1
titleOfInvention Methods of wound closure and treatment
abstract Dry anti-microbial powder is applied to an incision or wound and surrounding area. A skin closure device is applied to the incision or wound. The incision or wound is closed, either before the closure device is applied or with closure device application. A sterile island dressing is then be applied over the incision or wound with the closure device and anti-microbial powder applied. The absorbent pad of the dressing can be applied directly over the incision or wound to absorb excess blood, pus, or other exudate. The anti-microbial powder mixes with the exudate before or as the exudate is absorbed. The anti-microbial powder in the exudate mixture reduces bacterial and/or microbial growth in the mixture, thereby reducing the infection risk to the closed incision or wound, as well as reducing fouling of the wound dressing and undesirable smells.
priorityDate 2017-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425950
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID115087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227357826
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9797796
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9818469
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5018304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412491
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412490
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23667642
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425951

Total number of triples: 33.